Source Code Name Case count Share of cases (%)
REIMB REIMB_KELA(317)_ICD10(L20) Topical pimecrolimus and tacrolimus, Atopic dermatitis 1719
REIMB REIMB_KELA(317)_ICD10(L200) Topical pimecrolimus and tacrolimus, Besnier's prurigo 931
REIMB REIMB_KELA(134)_ICD10(L400) General erythroderma, Psoriasis vulgaris 194
REIMB REIMB_KELA(134)_ICD10(L26) General erythroderma, Exfoliative dermatitis 91
REIMB REIMB_KELA(134)_ICD9(NA) General erythroderma, Name not found 68
REIMB REIMB_KELA(395)_ICD10(L20) Dupilumab, Atopic dermatitis 53
REIMB REIMB_KELA(134)_ICD10(L20) General erythroderma, Atopic dermatitis 47
REIMB REIMB_KELA(395)_ICD10(L200) Dupilumab, Besnier's prurigo 41
REIMB REIMB_KELA(134)_ICD8(NA) General erythroderma, Name not found 23
REIMB REIMB_KELA(395)_ICD10(J45) Dupilumab, Asthma 20
REIMB REIMB_KELA(134)_ICD10(L200) General erythroderma, Besnier's prurigo 14
REIMB REIMB_KELA(134)_ICD9(6961A) General erythroderma, Psoriasis and similar disorders, Other psoriasis 14
REIMB REIMB_KELA(317)_ICD10(L209) Topical pimecrolimus and tacrolimus, Atopic dermatitis, unspecified 13
REIMB REIMB_KELA(134)_ICD10(NA) General erythroderma, Name not found 9
REIMB REIMB_KELA(395)_ICD10(J451) Dupilumab, Nonallergic asthma 6
REIMB REIMB_KELA(134)_ICD10(L53) General erythroderma, Other erythematous conditions 5
REIMB REIMB_KELA(395)_ICD10(J450) Dupilumab, Predominantly allergic asthma 5